• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis (2100)
Event Date 10/03/2019
Event Type  Injury  
Manufacturer Narrative
(b)(6).
 
Event Description
It was reported that acute thrombus occlusion occurred.Two 6x120x130 and a 7x80x130 eluvia self expanding drug eluting stents were selected for a chronic total occlusion (cto) procedure in the mildly tortuous superficial femoral artery (sfa).An antegrade and popliteal artery bidirectional approach was used to access the lesion.The procedure was successful and three devices were placed via the pull through method.Manual pressure was applied to the femoral with immobilization for six hours.The physician felt that the pulse was weak.Once the hemostatic device was removed the following day, the physician checked the pulse by palpation and did not feel the pulse and diagnosed acute thrombosis.The eluvia stent was aspirated and then a non-bsc stent was placed inside the eluvia stent.After the additional intervention, the patient had improved blood flow and no additional complications were reported.The physician consulted a colleague who felt that the thrombosis was cause by pressure on the puncture site, though the thrombogenicity unique to drug eluting stents (des) may have influenced.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key9555276
MDR Text Key173971027
Report Number2134265-2020-00012
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 01/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/27/2021
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0023576861
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/28/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-